BRAF Inhibitors for BRAF V600E Mutant Colorectal Cancers: Literature Survey and Case Report

Case Reports in Surgery
Yasar Subutay PekerYusuf Peker

Abstract

The main method of fighting against colon cancer is targeted treatment. BRAF inhibitors, which are accepted as standard treatment for V600E mutant malign melanomas, are the newest approach for targeted treatment of V600E mutant colorectal cancers. In this case report, we share our experience about the use of BRAF inhibitor vemurafenib on a V600E mutant metastatic right colon adenocarcinoma patient. A 59-year-old male with only lung multiple metastatic V600E mutant right colon cancer presented to our clinic. The patient was evaluated and FOLFOX + bevacizumab treatment was initiated, which was then continued with vemurafenib. A remarkable response was achieved with vemurafenib treatment in which the drug resistance occurred approximately in the sixth month. Even though the patient benefited majorly from vemurafenib, he died on the 20th month of the diagnosis. The expected overall survival for metastatic V600E mutant colon adenocarcinoma patients is 4.7 months. BRAF inhibitors provide new treatment alternatives for V600E mutant colorectal cancers, with prolonged overall survival. BRAF inhibitors in combination with MEK inhibitors are reported as feasible treatment to overcome BRAF inhibitor drug resistance on which phase studies a...Continue Reading

References

Aug 29, 2002·Nature·Harith RajagopalanVictor E Velculescu
Apr 23, 2008·Pathology·Yi Hui TanRichie Soong
Jul 22, 2008·Magyar onkologia·József Tímár, István Láng
Mar 27, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Carsten BokemeyerClaus-Henning Köhne
Mar 22, 2013·Bratislavské lekárske listy·J VodickaM Rousarova
Aug 1, 2013·International Journal of Colorectal Disease·Shunsuke TsukamotoAkio Shiomi
Dec 4, 2014·Hormones & Cancer·M E CabanillasG Falchook
May 16, 2015·Expert Review of Molecular Diagnostics·Mario ScartozziStefano Cascinu
Sep 24, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ryan B CorcoranScott Kopetz
Dec 24, 2015·Journal of Gastrointestinal Oncology·Ryan B Corcoran
Jan 16, 2016·Annual Review of Medicine·Warren Fiskus, Nicholas Mitsiades
Apr 5, 2016·Asian Pacific Journal of Cancer Prevention : APJCP·Orhan GorukmezOzkan Kanat
Jul 19, 2016·Annals of Translational Medicine·José Luís ManzanoAnna Martínez-Cardús
Oct 18, 2016·Journal of Gastrointestinal Oncology·Jun GongMarwan Fakih
Nov 12, 2016·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·L GhanipourH Birgisson
Dec 21, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J F SeligmannG Middleton
Feb 15, 2017·Journal of Surgical Oncology·Jeffrey DouaiherChandrakanth Are
Mar 10, 2017·Handbook of Experimental Pharmacology·Matthew Winder, Amaya Virós
Mar 17, 2017·Cancer Metastasis Reviews·Paola Queirolo, Francesco Spagnolo
Mar 21, 2017·Handbook of Experimental Pharmacology·Rodrigo N RamosEmanuela Romano

❮ Previous
Next ❯

Methods Mentioned

BETA
X-ray
biopsy
dissection

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
Oliver GautschiJoachim Diebold
Lung Cancer : Journal of the International Association for the Study of Lung Cancer
Oliver GautschiJoachim Diebold
Annals of Oncology : Official Journal of the European Society for Medical Oncology
T MasuishiK Muro
The New England Journal of Medicine
Paul B ChapmanBRIM-3 Study Group
© 2022 Meta ULC. All rights reserved